Sort
40,608 grants matching “prostate cancer”
Core B - Animal Core
$334,831Evan Todd Keller · University Of Michigan At Ann Arbor · P01 · FY2024 · CA
Annotating the Role of Dysregulated Inositol Phosphate Metabolism in Malignant Ca
$334,803Daniel Nomura · University Of California Berkeley · R01 · FY2016 · CA
Project 2: Re-directing the Sensitivity of Metastatic Castration-Resistant Prostate Cancer to Immunotherapy
$334,800Jennifer D Wu · Northwestern University At Chicago · P50 · FY2023 · CA
Project 2: Re-directing the Sensitivity of Metastatic Castration-Resistant Prostate Cancer to Immunotherapy
$334,798Jennifer D Wu · Northwestern University At Chicago · P50 · FY2022 · CA
VARIATIONS OF HUMAN DNA POLYMERASE GENES AS BIOMARKERS OF PROSTATE CANCER PROGRESSION
$334,765The Administrators Of Tulane Educational Fund · · FY2010 · Department of the Army
External validation of GEMCaP, a prognostic DNA biomarker set for CaP recurrence
$334,728Pamela L Paris · University Of California, San Francisco · R01 · FY2015 · CA
The MRAD9 Radioresistance Gene
$334,719Howard B Lieberman · Columbia University Health Sciences · R01 · FY2012 · GM
The MRAD9 Radioresistance Gene
$334,719Howard B Lieberman · Columbia University Health Sciences · R01 · FY2011 · GM
Improving Biopsies using Magnetic Nanoparticles
$334,717Edward R Flynn · Senior Scientific · R44 · FY2008 · CA
GPR30 and Hepatic Cholesterol Homeostasis
$334,698David Q Wang · Albert Einstein College Of Medicine, Inc · R01 · FY2017 · DK
Cell-Surface Interactions in Pathogenesis
$334,690Kenneth Yamada · National Institute Of Dental & Craniofacial Research · ZIA · FY2009 · DE
The role of KLF5 in GI epithelial homeostasis and disease
$334,688Jonathan P Katz · University Of Pennsylvania · R01 · FY2008 · DK
The role of KLF5 in GI epithelial homeostasis and disease
$334,688Jonathan P Katz · University Of Pennsylvania · R01 · FY2009 · DK
CANCER AND LEUKEMIA GROUP B--RPCI/SUNYAB
$334,685Roswell Park Cancer Institute Corp · U10 · FY2001 · CA
Reduced-Order Constrained Optimization for Rapid IMRT and VMAT Treatment Planning
$334,665Richard J Radke · Rensselaer Polytechnic Institute · R01 · FY2013 · CA
Adaptive resistance to AR inhibitors in hypoxia by GPT1
$334,662Zheng David Qian · Oregon Health & Science University · R01 · FY2024 · CA
Targeting Nanoparticle DNA Delivery to Prostate Tumors
$334,661Janet A. Sawicki · Lankenau Institute For Medical Research · R01 · FY2009 · CA
Structure-Functions Studies of Twist1-induced Radioresistance in Lung Cancer
$334,656Phuoc T. Tran · Johns Hopkins University · R01 · FY2014 · CA
Prostate Cancer Prevention by Procyanidins in Grape Seed Extract
$334,640Chapla Agarwal · University Of Colorado Denver · R01 · FY2008 · CA
Xenogen IVIS-200 Bioluminescent Imaging System
$334,600Alan Pollack · Fox Chase Cancer Center · S10 · FY2007 · RR
Phosphorylation-dependent regulation of GLI transcription factors
$334,562Scott Atwood · University Of California-Irvine · R01 · FY2023 · CA
T VS DHT SPECIFIC ANTIANDROGENS IN PROSTATE CANCER
$334,543University Of Rochester · R01 · FY2000 · CA
High-frequency Irreversible Electroporation (H-FIRE) combinatorial GBM treatment
$334,484Rafael Vidal Davalos · Virginia Polytechnic Inst And St Univ · R01 · FY2017 · CA
PLANT ANTITUMOR AGENTS
$334,474University Of North Carolina Chapel Hill · R01 · FY2005 · CA
Role of small molecule interactions and multiprotein assemblies in CYP1B1 disease-associated function and dysfunction
$334,471Edith C Glazer · University Of Kentucky · R01 · FY2021 · GM